Focused Investors LLC lessened its stake in The Cigna Group (NYSE:CI - Free Report) by 1.8% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 539,900 shares of the health services provider's stock after selling 10,000 shares during the quarter. The Cigna Group comprises approximately 5.7% of Focused Investors LLC's holdings, making the stock its 5th biggest holding. Focused Investors LLC owned approximately 0.19% of The Cigna Group worth $187,043,000 at the end of the most recent reporting period.
Other institutional investors also recently made changes to their positions in the company. Checchi Capital Advisers LLC boosted its holdings in The Cigna Group by 0.9% in the second quarter. Checchi Capital Advisers LLC now owns 3,584 shares of the health services provider's stock valued at $1,185,000 after purchasing an additional 31 shares during the last quarter. Benjamin F. Edwards & Company Inc. raised its position in shares of The Cigna Group by 1.4% during the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 2,206 shares of the health services provider's stock worth $729,000 after buying an additional 31 shares in the last quarter. IFG Advisors LLC lifted its position in The Cigna Group by 4.6% in the third quarter. IFG Advisors LLC now owns 699 shares of the health services provider's stock worth $242,000 after purchasing an additional 31 shares during the period. McClarren Financial Advisors Inc. boosted its stake in The Cigna Group by 4.7% during the third quarter. McClarren Financial Advisors Inc. now owns 692 shares of the health services provider's stock valued at $240,000 after buying an additional 31 shares in the last quarter. Finally, Capital Investment Advisors LLC raised its holdings in shares of The Cigna Group by 2.9% in the 2nd quarter. Capital Investment Advisors LLC now owns 1,122 shares of the health services provider's stock worth $371,000 after purchasing an additional 32 shares in the last quarter. 86.99% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
A number of equities research analysts have commented on the company. JPMorgan Chase & Co. raised their price objective on The Cigna Group from $435.00 to $438.00 and gave the stock an "overweight" rating in a research report on Wednesday, August 21st. StockNews.com cut The Cigna Group from a "strong-buy" rating to a "buy" rating in a research report on Monday, November 4th. Cantor Fitzgerald reaffirmed an "overweight" rating and set a $400.00 price objective on shares of The Cigna Group in a report on Wednesday, October 23rd. Jefferies Financial Group lifted their price target on The Cigna Group from $402.00 to $422.00 and gave the stock a "buy" rating in a research report on Tuesday, September 17th. Finally, Barclays lifted their target price on The Cigna Group from $405.00 to $420.00 and gave the stock an "overweight" rating in a research report on Tuesday, November 5th. One analyst has rated the stock with a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Buy" and an average target price of $394.64.
Check Out Our Latest Research Report on CI
The Cigna Group Trading Down 0.7 %
Shares of NYSE CI traded down $2.36 during midday trading on Friday, reaching $321.52. 1,650,180 shares of the stock were exchanged, compared to its average volume of 2,250,354. The Cigna Group has a 12 month low of $253.95 and a 12 month high of $370.83. The company has a market capitalization of $89.43 billion, a price-to-earnings ratio of 30.33, a P/E/G ratio of 0.97 and a beta of 0.51. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.72 and a quick ratio of 0.72. The business has a 50-day simple moving average of $338.88 and a two-hundred day simple moving average of $339.55.
The Cigna Group (NYSE:CI - Get Free Report) last posted its earnings results on Thursday, October 31st. The health services provider reported $7.51 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $7.22 by $0.29. The firm had revenue of $63.70 billion during the quarter, compared to analysts' expectations of $59.58 billion. The Cigna Group had a return on equity of 18.42% and a net margin of 1.31%. The company's revenue was up 29.8% on a year-over-year basis. During the same period in the previous year, the firm earned $6.77 earnings per share. As a group, equities research analysts expect that The Cigna Group will post 28.5 EPS for the current year.
The Cigna Group Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Thursday, December 19th. Investors of record on Wednesday, December 4th will be paid a $1.40 dividend. This represents a $5.60 dividend on an annualized basis and a yield of 1.74%. The ex-dividend date of this dividend is Wednesday, December 4th. The Cigna Group's payout ratio is presently 52.83%.
Insiders Place Their Bets
In other news, Director William J. Delaney III sold 2,691 shares of the business's stock in a transaction dated Monday, August 19th. The shares were sold at an average price of $342.68, for a total transaction of $922,151.88. Following the transaction, the director now directly owns 17,539 shares in the company, valued at $6,010,264.52. The trade was a 13.30 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 0.60% of the company's stock.
The Cigna Group Profile
(
Free Report)
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Featured Articles
Before you consider The Cigna Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Cigna Group wasn't on the list.
While The Cigna Group currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.